Renal inflammation: targeted iron oxide nanoparticles for molecular MR imaging in mice. - Wikidata - awgldk - TriplyDB

Renal inflammation: targeted iron oxide nanoparticles for molecular MR imaging in mice.

Renal inflammation: targeted iron oxide nanoparticles for molecular MR imaging in mice.

http://www.wikidata.org/entity/Q33807173

about

Non-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosus Advanced and Conventional Magnetic Resonance Imaging in Neuropsychiatric Lupus Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation Therapeutic regulation of complement in patients with renal disease - where is the promise?Nanosized contrast agents to noninvasively detect kidney inflammation by magnetic resonance imaging Iron oxide-based nanostructures for MRI and magnetic hyperthermia The Complement System and Antibody-Mediated Transplant Rejection Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy Translational imaging endpoints to predict treatment response to novel targeted anticancer agents.Hydrophilic packaging of iron oxide nanoclusters for highly sensitive imaging.MRI tools for assessment of microstructure and nephron function of the kidney.Electrostatic Steering Accelerates C3d:CR2 Association.Nanoparticle-Based Magnetic Resonance Imaging on Tumor-Associated Macrophages and Inflammation.Recombinant complement receptor 2 radiolabeled with [99mTc(CO)3]+: a potential new radiopharmaceutical for imaging activated complement Serial non-invasive monitoring of renal disease following immune-mediated injury using near-infrared optical imaging.Serial non-invasive assessment of antibody induced nephritis in mice using positron emission tomography.C5b-9-targeted molecular MR imaging in rats with Heymann nephritis: a new approach in the evaluation of nephrotic syndrome.Current MRI techniques for the assessment of renal disease Radiologic imaging of the renal parenchyma structure and function.Detection of glomerular complement C3 fragments by magnetic resonance imaging in murine lupus nephritis Noninvasive Imaging of Activated Complement in Ischemia-Reperfusion Injury Post-Cardiac Transplant Progress and Trends in Complement Therapeutics Strategies for Target-Specific Contrast Agents for Magnetic Resonance Imaging Nanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus in mice.Detection of complement activation using monoclonal antibodies against C3d.New therapeutic and diagnostic opportunities for injured tissue-specific targeting of complement inhibitors and imaging modalities.Applications of nanoparticles in the detection and treatment of kidney diseases Engineered nanoparticles for biomolecular imaging.A molecular imaging primer: modalities, imaging agents, and applications.Imaging patients with renal impairment.Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease.Activatable interpolymer complex-superparamagnetic iron oxide nanoparticles as magnetic resonance contrast agents sensitive to oxidative stress.Polyacrylic acid-coated and non-coated iron oxide nanoparticles induce cytokine activation in human blood cells through TAK1, p38 MAPK and JNK pro-inflammatory pathways.Determination of liver-specific r2 * of a highly monodisperse USPIO by (59) Fe iron core-labeling in mice at 3 T MRI

P2860

Q26796871-4ADF3F57-B6B9-4EFE-B894-7C6ED47ADF62 Q26799922-EC8D3B30-C239-4B4E-8905-21D2AD983E3D Q26830874-2879913F-602B-4EB3-B2AC-39CBA60A5452 Q26851705-0BBDA0F7-EC7A-498E-B9FE-89DD4DB20024 Q26864381-6074161B-CCB2-4E70-96F7-251266C4890A Q27027859-1218F317-1E13-460B-B295-4BFA7B54FDE7 Q28087773-110A5585-7849-4A67-82BD-4D85B412B3EA Q28354224-1700BB2D-C67A-43DD-A954-C7D5D3613366 Q30465097-7B95343F-7CB0-4BAC-B757-9B601E955122 Q30988368-917D0166-F604-42FF-A5B8-B921A9421B24 Q31130873-A278B4A8-2515-4C21-8B34-0D3DA3B4AA08 Q33594349-4372388C-C4DE-4637-9C6F-9A163AFA2CBF Q33710955-7E481E58-BB6B-433A-9594-A4A8B417E1BB Q33873704-4086BC47-CD43-4DB4-9CB1-F9BEE6C838E5 Q34437854-845ED5E3-0BB1-443C-8033-4B425BCAE936 Q34608556-B334889A-BA45-4703-9AF5-6C79693BEF4B Q35181694-98BC58DE-6488-4B36-AA03-A8B3AB4679BA Q35742620-67F5F290-2DD8-4C78-863D-EE735DE8939B Q35986377-6B7FFE08-EAC9-4F38-9E96-2E584A90D748 Q36034520-167EA579-CEC4-403C-A320-E370C290D054 Q36302489-52B3593E-C20D-4E39-91EC-0980A886F76A Q36479278-0A54E20D-6C7C-4A1A-B998-FDFB1B2C125D Q36517070-62BB758D-7659-45F5-AC37-8DB86FB69DD3 Q36733468-00AAE5EC-D126-41A2-9B00-BD5A352A6117 Q36793448-03E647BB-4798-43CC-B84D-FDA955E246C2 Q37180522-F433EFFA-6308-4F27-8E1A-6D459B3FDDD5 Q37298541-07FEC259-4E83-437E-A912-0770381B1495 Q37895953-FFDBB974-29E0-4161-93AC-F508C2B7587F Q38005672-D4B74100-D641-411F-9E5B-B1CF7A8FB04B Q38789239-2A5205AB-6445-4896-B197-49E98616F18A Q39314491-B6BD24B8-D435-479C-89F8-7B1487D932F6 Q47873356-7BB5BB6C-B1F6-44E1-AC42-3F455E471ED2 Q55072019-C0932ECE-7D2A-4621-99C7-56A2C7E2A8FA Q57183010-3474AC18-DCDC-41B6-924C-C4D2621CCC46

P2860

Renal inflammation: targeted iron oxide nanoparticles for molecular MR imaging in mice.

http://www.wikidata.org/entity/Q33807173

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Renal inflammation: targeted iron oxide nanoparticles for molecular MR imaging in mice.

@ast

Renal inflammation: targeted iron oxide nanoparticles for molecular MR imaging in mice.

@en

type

label

Renal inflammation: targeted iron oxide nanoparticles for molecular MR imaging in mice.

@ast

Renal inflammation: targeted iron oxide nanoparticles for molecular MR imaging in mice.

@en

prefLabel

Renal inflammation: targeted iron oxide nanoparticles for molecular MR imaging in mice.

@ast

Renal inflammation: targeted iron oxide nanoparticles for molecular MR imaging in mice.

@en

P1433

Q33807173-A9BC6770-6785-4EF0-864D-FC224E8C7DE9

P1476

Q33807173-E67E7F4E-6236-47EA-BFE9-DD415DE2255B

P2093

Q33807173-0479C261-8A57-41B1-81F5-14D76B31A72D

Q33807173-0B5168B2-3BC7-4F3E-A04B-70FD06CD45A3

Q33807173-32B3C737-CA2F-4146-BB63-38F04C950FCD

Q33807173-3B1165DB-3995-4CF6-A6D8-E32EEB2CC9ED

Q33807173-7297B803-31DE-4BDE-9FF7-E9AD6C63DAFF

Q33807173-8CFB9AD5-70E9-4168-8E13-7AD1036C0565

Q33807173-935A6CF2-DECD-4D06-A6F7-17BEE616A0AF

Q33807173-EDDBE51A-1948-4F79-ABD4-FC2FC2BC62F5

P2860

Q33807173-17FDB13E-7D8B-4C7B-BF70-03A8B3C34631

Q33807173-18E2AF45-3909-41FE-8F58-233D4668A3DF

Q33807173-565ED7C0-3E56-47C6-9D84-87B382EA8866

Q33807173-6303CDF6-88A0-4BE4-8048-57AFD01BCEB7

Q33807173-67F0B092-E74C-47FC-B5E5-86463BC81317

Q33807173-8295AC75-25FF-43A2-882F-132E60A838E1

Q33807173-8EF4E37B-7EBF-43EB-9C91-50B8C870D821

Q33807173-9D83E219-16FA-4D56-9FD6-A0DAAC06AD39

Q33807173-A086939D-A9FA-4954-A8BA-2192064DB241

Q33807173-A2BF9A85-F2C4-44D3-8B88-D69894EF2548

P304

Q33807173-48F4FE92-CE5C-4353-A2D7-5D2F74F30D8B

P31

Q33807173-2894BB78-CF43-4967-89C6-240E08206BC6

P356

Q33807173-9B78BE5B-CE7B-49F2-86F1-2035AE0DAAD6

P407

Q33807173-523F6181-79FC-4784-B546-DD658CC3B6A2

P433

Q33807173-601E3BA4-9009-4B20-B0EB-086212CE8FFB

P478

Q33807173-63EAA58A-1026-4E7A-9E44-F4D198D1CB95

P577

Q33807173-F4DE3FA3-E35A-4B1A-909B-3CFBBEAABDF8

P5875

Q33807173-1BB82C84-2FD3-4277-9413-E3470CD6DBBB

P698

Q33807173-FFC7F13A-DF7B-47D9-A0F1-3B5821953E9D

P921

Q33807173-8628D670-057D-4933-B912-D6147FD5E944

Q33807173-879B7C4D-9239-4228-8E49-C0318ECD71E4

P932

Q33807173-DD5E9EF3-D307-4277-83F9-AF9397FC31C3

P356

RADIOL.09091134

P1433

P1476

Renal inflammation: targeted iron oxide nanoparticles for molecular MR imaging in mice.

@en

P2093

Brandon Renner

http://www.w3.org/2001/XMLSchema#string

Brian A Larsen

http://www.w3.org/2001/XMLSchema#string

Conrad R Stoldt

http://www.w3.org/2001/XMLSchema#string

Erica L Bradshaw-Pierce

http://www.w3.org/2001/XMLSchema#string

Joshua M Thurman

http://www.w3.org/2001/XMLSchema#string

Kendra M Hasebroock

http://www.w3.org/2001/XMLSchema#string

Natalie J Serkova

http://www.w3.org/2001/XMLSchema#string

V Michael Holers

http://www.w3.org/2001/XMLSchema#string

P2860

Complement. Second of two parts

Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg.

Molecular magnetic resonance imaging with targeted contrast agents.

Outcomes of percutaneous kidney biopsy, including those of solitary native kidneys.

Functional magnetic resonance imaging of the kidney using macromolecular contrast agents.

Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection.

Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging.

Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells.

Extended flexible linker structures in the complement chimaeric conjugate CR2-Ig by scattering, analytical ultracentrifugation and constrained modelling: implications for function and therapy.

Controlled aggregation of superparamagnetic iron oxide nanoparticles for the development of molecular magnetic resonance imaging probes.

P304

517-526

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RADIOL.09091134

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

255

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42440779

http://www.w3.org/2001/XMLSchema#string

P698

20332377

http://www.w3.org/2001/XMLSchema#string

P921

P932

2858816

http://www.w3.org/2001/XMLSchema#string